Diagnostic Definition and Clinical Implications of ARDS

Diagnostic Criteria

Timing requirement – ARDS should be diagnosed when acute respiratory symptoms develop within 1 week of a known clinical insult or new/worsening respiratory presentation. 1
Imaging requirement – Bilateral pulmonary opacities on chest radiograph or CT that cannot be fully explained by pleural effusions, lobar collapse, or nodules are mandatory for diagnosis. 1
Exclusion of cardiogenic edema – When no clear ARDS risk factor is present, objective cardiac assessment (e.g., echocardiography) must be performed to rule out hydrostatic pulmonary edema. 2

Inflammatory and barrier injury – ARDS is characterized by leukocyte infiltration, local immune activation, and injury to alveolar endothelial and epithelial cells, leading to increased pulmonary vascular permeability. 1
Pulmonary edema and loss of aerated tissue – The increased permeability results in acute pulmonary edema and a reduction of normally aerated lung regions. 1
Diffuse alveolar damage (DAD) progression – Histologically, ARDS evolves through exudative, fibroproliferative, and fibrotic phases with hyaline membrane formation. 3
Surfactant depletion and shunting – The disease process depletes surfactant, creates extensive intrapulmonary shunting, and produces profound hypoxemia. 4

In‑hospital mortality – Despite the refined Berlin definition, overall in‑hospital mortality for ARDS patients remains approximately 30–40 %. [1][5]

PEEP‑adjusted oxygenation measurement – The PaO₂/FiO₂ ratio must be calculated while the patient is receiving a minimum of 5 cmH₂O of positive end‑expiratory pressure; otherwise severity staging may be inaccurate. 2
Cardiogenic cause exclusion – Failure to actively rule out cardiac failure (e.g., via echocardiography) can lead to misclassification of non‑ARDS pulmonary edema as ARDS. 2
Mimicking conditions – Diffuse interstitial lung diseases, widespread pulmonary infections, and drug‑induced lung injury can mimic ARDS radiographically and clinically, necessitating alternative therapeutic approaches. 2

Multidimensional heterogeneity – ARDS encompasses wide variation across aetiological, physiological, and biological domains, with no single criterion required for diagnosis, contributing to patient‑level heterogeneity. [1][6]
Impact on clinical trials – This intrinsic heterogeneity has been a major factor in the repeated failure of therapeutic trials, as interventions targeting specific pathophysiological mechanisms may only benefit selected subgroups. 6

Bilateral pulmonary opacities on chest radiograph or CT that cannot be fully explained by pleural effusions, lobar collapse, or nodules are required for ARDS diagnosis. 7
The PaO₂/FiO₂ ratio used to assess oxygenation impairment must be measured while the patient is receiving a minimum of 5 cmH₂O positive end‑expiratory pressure (PEEP). 7

ARDS is characterized by an inflammatory injury marked by leukocyte infiltration and activation of local immune responses that damage alveolar endothelial and epithelial cells. 7
Damage to the alveolar‑capillary barrier increases pulmonary vascular permeability, leading to acute protein‑rich pulmonary edema and loss of aerated lung tissue. 7

Standard chest radiographs correlate poorly with the severity of hypoxemia and clinical outcomes; infiltrates may appear asymmetric or patchy rather than diffuse, which can cause misclassification. 8
Misclassification of the cause of pulmonary edema (cardiogenic vs. non‑cardiogenic) can lead to inappropriate management; echocardiography should be used to exclude hydrostatic edema when the diagnosis is uncertain. (implicit from criteria, no specific citation)

In‑hospital mortality for patients meeting ARDS criteria remains approximately 30–40 % despite advances in supportive care. 7
Death is most often due to multiorgan failure and unresolved sepsis rather than isolated respiratory failure. 8

ARDS may be triggered by direct pulmonary insults (e.g., pneumonia, aspiration) or indirect extrapulmonary insults (e.g., sepsis, pancreatitis); specifying the exact trigger is not required for diagnosis. 9
Even among patients who meet identical diagnostic criteria, there is wide variation in respiratory mechanics, dead‑space ventilation, and ventilatory requirements, reflecting substantial physiological heterogeneity. 9